Chronic Back Pain: Herniated Discs, Spinal Stenosis, and Evidence-Based Pain Relief

The Scope of the Back Pain Crisis

Chronic low back pain is the single leading cause of disability globally, affecting an estimated 540 million people worldwide at any point in time and generating the largest proportion of years lived with disability of any condition in the 2019 Global Burden of Disease study. In the United States, chronic back pain accounts for more lost workdays, more healthcare visits, and more total disability spending than any other musculoskeletal condition, with direct and indirect costs estimated at $100–200 billion annually. Despite this extraordinary clinical and economic burden, chronic back pain remains among the most persistently undertreated conditions in medicine, with studies consistently documenting that 40–60% of affected patients report inadequate pain control.

The pathological conditions generating chronic back pain are diverse, but two specific spinal pathologies, herniated intervertebral discs and spinal stenosis, account for a large proportion of the clinically significant chronic back pain that requires medical management. Herniated discs occur when the nucleus pulposus, the gelatinous core of the intervertebral disc, protrudes through the annulus fibrosus (the disc’s outer ring) under mechanical loading, typically pressing against nerve roots or the spinal cord in ways that produce both the axial back pain of disc disruption and the radicular leg pain of nerve root compression. Lumbar disc herniations producing L4, L5, or S1 nerve root compression generate the sciatica syndrome, radiating pain down the posterior leg to the foot following specific dermatomal patterns, that is one of the most recognizable and most debilitating back pain presentations.

Spinal stenosis, narrowing of the spinal canal or neural foramina that houses the spinal cord and nerve roots, produces a characteristic clinical syndrome of neurogenic claudication: bilateral leg pain, heaviness, and weakness brought on by walking or standing that is relieved by sitting or forward flexion. Lumbar stenosis from combined disc degeneration, facet joint hypertrophy, and ligamentum flavum thickening reduces the space available for neural structures in ways that produce ischemic and compressive nerve injury with ambulation, creating the functional limitation of being able to walk only short distances before leg pain forces rest. Cervical stenosis produces upper extremity symptoms and, in severe cases, myelopathy from direct spinal cord compression.

Pharmacological Pain Management for Disc and Stenosis Pain

The pharmacological management of herniated disc and spinal stenosis pain targets both the nociceptive inflammatory pain of disc disruption and the neuropathic pain of nerve root compression, a mixed pain profile that benefits from agents addressing both mechanisms. NSAIDs provide anti inflammatory analgesic coverage for the inflammatory component, with naproxen and diclofenac among the most used for spinal inflammatory pain. Short courses of oral corticosteroids (dexamethasone, prednisone) provide more potent anti inflammatory effect for acute radicular pain from severe disc herniation, reducing the periradicular edema that amplifies nerve root compression pain.

Gabapentin is widely prescribed for the neuropathic radicular component of disc and stenosis pain, the burning, shooting, and tingling leg pain that reflects nerve root sensitization from compression and inflammation. Multiple clinical studies support gabapentin’s meaningful reduction of radicular pain intensity in lumbar disc herniation and stenosis, with the neuropathic features (burning quality, dermatomal distribution, allodynia, nocturnal exacerbation) most predictive of gabapentin response. Starting at 300mg at bedtime and titrating toward 1,800mg/day over several weeks provides the therapeutic plasma levels that radicular neuropathic pain management requires.

Tramadol addresses the mixed nociceptive neuropathic pain profile of disc and stenosis conditions through its dual mechanism, providing opioidergic and monoaminergic analgesic coverage without the regulatory burden of Schedule II opioids, making it an important intermediate step analgesic for patients whose pain severity exceeds what NSAIDs and gabapentinoids can adequately control. Tramadol’s extended release formulation provides around the clock analgesic coverage for the persistent daily back and radicular pain that episodic immediate release dosing may not consistently address.

For moderate to severe chronic back pain from disc or stenosis pathology that has not responded to non opioid management, documented through adequate trials of physical therapy, NSAIDs, gabapentin, and tramadol, opioid analgesics including hydrocodone acetaminophen (Vicodin), oxycodone, and Percocet (oxycodone acetaminophen) provide pain relief under appropriate medical supervision and monitoring. Patients managing chronic spinal pain who access their prescribed analgesics through a licensed online pharmacy benefit from the convenience of home delivery for their ongoing medication needs while maintaining the prescription verification and pharmacist oversight that responsible opioid and non opioid analgesic management requires.

Interventional Pain Management for Spinal Pathology

Epidural steroid injections (ESIs), delivery of corticosteroid and local anesthetic to the epidural space adjacent to compressed nerve roots, provide targeted anti inflammatory and analgesic coverage for the radicular pain of disc herniation and stenosis. The three approaches, interlaminar, transforaminal, and caudal, deliver medication to different zones within the epidural space, with the transforaminal approach providing the most direct delivery to the specific inflamed nerve root responsible for the radicular pain. ESI benefit typically lasts 4–12 weeks and does not address the underlying structural pathology, but provides sufficient pain relief to enable physical therapy participation that produces longer lasting functional improvement.

Medial branch nerve blocks and radiofrequency ablation address facet joint pain, a significant contributor to chronic axial back pain in degenerative spinal disease, by anesthetizing the medial branch nerves supplying facet joint capsule pain fibers. Radiofrequency ablation, which thermally ablates these medial branch nerves, provides 6–18 months of facet pain relief in appropriately selected patients, eliminating the facet contribution to chronic low back pain for sufficient duration to significantly reduce analgesic medication requirements.

Spinal cord stimulation, proven most effective for the radicular pain component of failed back surgery syndrome and refractory lumbar stenosis, provides the gate control inhibitory mechanism for leg pain that pharmacological agents cannot consistently replicate. For patients who have undergone lumbar surgery without adequate pain relief, the failed back surgery syndrome population, SCS significantly reduces both the radicular leg pain and the analgesic medication burden, improving function and quality of life through a mechanism independent of all pharmacological analgesics.

Physical Therapy and Rehabilitation: The Essential Complementary Intervention

Physical therapy is the most important non pharmacological intervention for chronic back pain from disc and stenosis pathology, providing both immediate pain relief through manual therapy and therapeutic exercise and long term structural and functional improvement through the restoration of spinal stability, flexibility, and movement patterns that pharmacological treatment cannot achieve. The evidence base for physical therapy in chronic low back pain consistently demonstrates outcomes comparable to or exceeding those from most pharmacological interventions for patients who engage with it consistently.

Core stabilization exercise, specifically targeting the deep spinal stabilizing muscles (multifidus, transversus abdominis) that protect intervertebral discs from the loading patterns that cause herniation and drive disc degeneration, is the foundational rehabilitation component for disc related back pain. When performed with adequate frequency and consistency, core stabilization programs reduce pain, improve function, and reduce the risk of disc herniation recurrence, outcomes that NSAIDs, opioids, and epidural injections cannot provide.

McKenzie method physical therapy, a directional preference based approach that identifies specific movement directions that centralize or reduce radicular pain, provides a particularly effective technique for disc herniation related sciatica, enabling patients to self manage acute disc pain exacerbations through movement patterns that reduce nerve root pressure. The combination of McKenzie directional exercise, core stabilization training, and appropriate pharmacological support with agents obtained from a licensed pharmacy, gabapentin for neuropathic radicular pain, tramadol or appropriate prescription analgesics for the overall pain burden, creates the most clinically comprehensive approach to disc and stenosis chronic back pain management.

Surgical Considerations and Long Term Back Pain Management

Spinal surgery, microdiscectomy for disc herniation producing refractory radicular pain or neurological deficit, laminectomy or laminotomy for spinal stenosis producing severe neurogenic claudication, achieves the best outcomes when the surgical indication is specific, the neurological findings are consistent with the imaging pathology, and the conservative treatment trial has been adequate before surgical referral. The evidence base for spinal surgery outcomes is strongest for radiculopathy with objective neurological deficit and for severe stenosis producing functionally limiting neurogenic claudication, conditions where the structural problem is clearly identified and its clinical consequences are unambiguous.

Patients who do not meet surgical criteria, or who choose conservative management over surgery, require a long term pain management framework that maintains function and quality of life while recognizing that structural spinal pathology is unlikely to fully resolve. This framework integrates consistent physical therapy for function maintenance, appropriate pharmacological analgesic support with dose optimization as symptoms fluctuate, periodic reassessment for interventional procedures as their benefit windows allow, and psychological coping skill development for the chronic pain experience that long standing spinal pathology produces.

Long term opioid therapy for chronic back pain, when other options have been systematically tried and documented as inadequate, requires the clinical infrastructure of an ongoing prescriber patient relationship with regular monitoring, urine drug screening, prescription monitoring program checks, and explicit function based treatment goals. Patients on chronic opioid therapy for back pain who manage their prescriptions through a certified online pharmacy alongside their prescriber monitoring maintain the pharmaceutical consistency that long term pain management requires while accessing the pharmacist clinical oversight that complete medication management benefits from.

Patient self efficacy, the confidence and skill to actively manage back pain through movement, self care practices, and knowledgeable use of prescribed medications, is among the strongest predictors of long term back pain outcomes. Patients who understand their condition, know how their medications work and when to use them, maintain consistent exercise and rehabilitation engagement, and access their prescribed medications reliably through a certified online pharmacy achieve the best functional outcomes from chronic spinal pain, demonstrating that active engagement with comprehensive management, rather than passive dependence on any single intervention, is the key determinant of long term recovery.

Chronic back pain from disc and stenosis pathology is best managed through a clinical approach that simultaneously addresses all contributing mechanisms, structural spinal pathology through appropriate interventional or surgical management, peripheral nociceptive pain through NSAIDs and targeted injections, neuropathic radicular pain through gabapentin, and overall pain burden through tramadol or opioid analgesics where clinically indicated. No single intervention addresses the full complexity of chronic spinal pain, and the best outcomes consistently emerge from the integration of multiple evidence based approaches rather than from seeking the single best treatment.